Phenotypic variability of sporadic human prion disease and its molecular basis: Past, present, and future

Acta Neuropathologica

Volumn 121, Issue 1, 2011, Pages 91-112

  Parchi, Piero ^a   Strammiello, Rosaria ^a   Giese, Armin ^b   Kretzschmar, Hans ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Creutzfeldt Jakob disease (CJD); Prion diseases; Sporadic CJD

Indexed keywords

PRION PROTEIN;

ALLELE; AMYLOID PLAQUE; BRAIN HOMOGENATE; CELL VACUOLE; CEREBRAL BLINDNESS; CODON; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; MOLECULAR TYPING; PHENOTYPE; PHENOTYPIC VARIATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN MISFOLDING; REVIEW; SPORADIC CREUTZFELDT JAKOB DISEASE; ANIMAL; CHEMISTRY; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DISEASE MODEL; FORECASTING; GENETIC POLYMORPHISM; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CODON; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS;

EID: 79959442590     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-010-0779-6     Document Type: Review

References (137)

1. Adams H, Beck E, Shenkin AM (1974) Creutzfeldt–Jakob disease: further similarities with kuru. J Neurol Neurosurg Psychiatry 37:195–200
2. Alema G, Bignami A (1959) Subacute degenerative presenile polioencephalopathy with akinetic stupor and decorticate rigidity with myoclonus (‘‘myoclonic’’ variety of the Jakob–Creutzfeldt disease). Riv Sper Freniatr Med Leg Alien Ment 83(4 Suppl):1485–1623
3. Aucouturier P, Kascsak RJ, Frangione B, Wisniewski T (1999) Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt–Jakob disease. Neurosci Lett 274:33–36
4. Baker CA, Lu ZY, Zaitsev I, Manuelidis L (1999) Microglial activation varies in different models of Creutzfeldt–Jakob disease. J Virol 73:5089–5097
5. Baron TG, Madec JY, Calavas D, Richard Y, Barillet F (2000) Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep. Neurosci Lett 284:175–178
6. Beck JA, Mead S, Campbell TA, Dickinson A, Wientjens DP, Croes EA, Van Duijn CM, Collinge J (2001) Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57:354–356
7. Berciano J, Berciano MT, Polo JM, Figols J, Ciudad J, Lafarga M (1990) Creutzfeldt–Jakob disease with severe involvement of cerebral white matter and cerebellum. Virchows Arch A Pathol Anat Histopathol 417:533–538
8. Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt–Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010
9. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H (1997) The cellular prion protein binds copper in vivo. Nature 390:684–687
10. Brown P, Cathala F, Castaigne P, Gajdusek DC (1986) Creutzfeldt–Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20:597–602
11. Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt–Jakob disease. Neurology 40:887–890
12. Brownell B, Oppenheimer DR (1965) An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt–Jakob Disease). J Neurol Neurosurg Psychiatry 28:350–361
13. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389: 498–501
14. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ, Gambetti P (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt–Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643–2658
15. Cali I, Castellani R, Yuan J, Al-Shekhlee A, Cohen ML, Xiao X, Moleres FJ, Parchi P, Zou WQ, Gambetti P (2006) Classification of sporadic Creutzfeldt–Jakob disease revisited. Brain 129: 2266–2277
16. Cancellotti E, Bradford BM, Tuzi NL, Hickey RD, Brown D, Brown KL, Barron RM, Kisielewski D, Piccardo P, Manson JC (2010) Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. J Virol 84:3464–3475
17. Capellari S, Parchi P, Russo CM, Sanford J, Sy MS, Gambetti P, Petersen RB (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157:613–622
18. Capellari S, Parchi P, Wolff BD, Campbell J, Atkinson R, Posey DM, Petersen RB, Gambetti P (2002) Creutzfeldt–Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 59:1628–1630
19. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P (2004) Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt–Jakob disease. Neurology 63:436–442
20. Caughey B, Raymond GJ, Kocisko DA, Lansbury PT Jr (1997) Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J Virol 71:4107–4110
21. Chou SM, Martin JD (1971) Kuru-plaques in a case of Creutzfeldt–Jakob disease. Acta Neuropathol 17:150–155
22. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690
23. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alperovitch A, Brandel JP, Mackenzie J, Murray K, Will RG (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt–Jakob disease. Brain 129:2278–2287
24. Cruz-Sanchez F, Lafuente J, Gertz HJ, Stoltenburg-Didinger G (1987) Spongiform encephalopathy with extensive involvement of white matter. J Neurol Sci 82:81–87
25. de Silva R, Ironside JW, McCardle L, Esmonde T, Bell J, Will R, Windl O, Dempster M, Estibeiro P, Lathe R (1994) Neuropathological phenotype and ‘prion protein’ genotype correlation in sporadic Creutzfeldt–Jakob disease. Neurosci Lett 179:50–52
26. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron 19:1337–1348
27. Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J (1991) CJD discrepancy. Nature 353:801–802
28. Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380–8388
29. Garcin RBS, Khochneviss AA (1963) Le syndrome de Creutzfeldt–Jakob et les syndromes corticotrices du presenium (a` l’occasion d’ observations anatomo-cliniques). Rev Neurol (Paris) 109:419–441
30. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8:449–457
31. Gmitterova K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I (2009) 14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes. Neurobiol Aging 30:1842–1850
32. Gomori AJ, Partnow MJ, Horoupian DS, Hirano A (1973) The ataxic form of Creutzfeldt–Jakob disease. Arch Neurol 29:318–323
33. Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119:89–105
34. Haik S, Galanaud D, Linguraru MG, Peoc’h K, Privat N, Faucheux BA, Ayache N, Hauw JJ, Dormont D, Brandel JP (2008) In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 65:545–549
35. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura Y, Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M (2005) Clinical diagnosis of MM2-type sporadic Creutzfeldt–Jakob disease. Neurology 64:643–648
36. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, Williams MC, McCardle L, MacKenzie J, Knight R, Will RG, Ironside JW (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: UK cases 1991–2002. Ann Neurol 55:851–859
37. Head MW, Ironside JW (2009) Sporadic Creutzfeldt–Jakob disease: discrete subtypes or a spectrum of disease? Brain 132:2627–2629
38. Heidenhain A (1929) Klinische und anatomische Untersuchungen u¨ber eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium. Z Ges Neurol Psychiatr 118:49–114
39. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schurmann P, Windl O, Brose N, Kretzschmar H (1999) Evidence of presynaptic location and function of the prion protein. J Neurosci 19:8866–8875
40. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389:448–450, 526
41. Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A, Poulter M, Wadsworth JD, Collinge J (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685
42. Hornshaw MP, McDermott JR, Candy JM, Lakey JH (1995) Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214: 993–999
43. Hsiao K, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1:68–71
44. Jakob A (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseurosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilkd 70:132–146
45. Jellinger K, Heiss WD, Deisenhammer E (1974) The ataxic (cerebellar) form of Creutzfeldt–Jakob disease. J Neurol 207:289–305
46. Jeong BH, Nam JH, Lee YJ, Lee KH, Jang MK, Carp RI, Lee HD, Ju YR, Ahn Jo S, Park KY, Kim YS (2004) Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet 49:319–324
47. Jones HR Jr, Hedley-Whyte ET, Freidberg SR, Baker RA (1985) Ataxic Creutzfeldt–Jakob disease: diagnostic techniques and neuropathologic observations in early disease. Neurology 35:254–257
48. Kitamoto T, Mohri S, Ironside JW, Miyoshi I, Tanaka T, Kitamoto N, Itohara S, Kasai N, Katsuki M, Higuchi J, Muramoto T, Shin RW (2002) Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem Biophys Res Commun 294:280–286
49. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236
50. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt–Jakob disease. Am J Pathol 140:1285–1294
51. Kitamoto T, Tateishi J (1994) Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci 343:391–398
52. Kobayashi A, Arima K, Ogawa M, Murata M, Fukuda T, Kitamoto T (2008) Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt–Jakob disease MM1 patients. Acta Neuropathol 116:561–566
53. Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84:3230–3238
54. Kobayashi A, Satoh S, Ironside JW, Mohri S, Kitamoto T (2005) Type 1 and type 2 human PrPSc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt–Jakob disease. J Gen Virol 86:237–240
55. Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, Parchi P, Gambetti P, Will R, Ironside J, Heinrich C, Tremblay P, DeArmond SJ, Prusiner SB (2003) Abbreviated incubation times for human prions in mice expressing a chimeric mouse–human prion protein transgene. Proc Natl Acad Sci USA 100:4784–4789
56. Kott E, Bornstein B, Sandbank U (1967) Ataxic form of Creutzfeldt–Jakob disease. Its relation to subacute spongiform encephalopathy. J Neurol Sci 5:107–113
57. Krebs B, Bader B, Klehmet J, Grasbon-Frodl E, Oertel WH, Zerr I, Stricker S, Zschenderlein R, Kretzschmar HA (2007) A novel subtype of Creutzfeldt–Jakob disease characterized by a small 6 kDa PrP fragment. Acta Neuropathol 114:195–199
58. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122:1–5
59. Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5:315–324
60. Krucke W, Beck E, Vitzthum HG (1973) Creutzfeldt–Jakob disease. Some unusual morphological features reminiscent of kuru. Z Neurol 206:1–24
61. Kuczius T, Koch R, Keyvani K, Karch H, Grassi J, Groschup MH (2007) Regional and phenotype heterogeneity of cellular prion proteins in the human brain. Eur J Neurosci 25:2649–2655
62. Laplanche JL, Delasnerie-Laupretre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, Launay JM (1994) Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. Neurology 44:2347–2351
63. Lasmezas CI, Fournier JG, Nouvel V, Boe H, Marce D, Lamoury F, Kopp N, Hauw JJ, Ironside J, Bruce M, Dormont D, Deslys JP (2001) Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt–Jakob disease: implications for human health. Proc Natl Acad Sci USA 98:4142–4147
64. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305:673–676
65. Levavasseur E, Laffont-Proust I, Morain E, Faucheux BA, Privat N, Peoc’h K, Sazdovitch V, Brandel JP, Hauw JJ, Haik S (2008) Regulating factors of PrP glycosylation in Creutzfeldt–Jakob disease—implications for the dissemination and the diagnosis of human prion strains. PLoS One 3:e2786
66. Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ (2005) Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 65:113–118
67. Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R, Rinaldi R, Testa C, Malucelli E, Mostacci B, Rizzo G, Pierangeli G, Cortelli P, Montagna P, Barbiroli B (2009) Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 132:2669–2679
68. Manners DN, Parchi P, Tonon C, Capellari S, Strammiello R, Testa C, Tani G, Malucelli E, Spagnolo C, Cortelli P, Montagna P, Lodi R, Barbiroli B (2009) Pathologic correlates of diffusion MRI changes in Creutzfeldt–Jakob disease. Neurology 72:1425–1431
69. Masters CL, Richardson EP Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt–Jakob disease). The nature and progression of spongiform change. Brain 101:333–344
70. Mastrianni JA, Nixon R, Layzer R, Telling GC, Han D, DeArmond SJ, Prusiner SB (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340:1630–1638
71. McCormack JE, Baybutt HN, Everington D, Will RG, Ironside JW, Manson JC (2002) PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt–Jakob Disease. Gene 288:139–146
72. Mead S, Mahal SP, Beck J, Campbell T, Farrall M, Fisher E, Collinge J (2001) Sporadic—but not variant—Creutzfeldt–Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet 69:1225–1235
73. Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Collins SJ, Smith P, Cras P, Jansen GH, Brandel JP, Coulthart MB, Roberts H, Van Everbroeck B, Galanaud D, Mellina V, Will RG, Zerr I (2009) MRI lesion profiles in sporadic Creutzfeldt–Jakob disease. Neurology 72:1994–2001
74. Meyer A, Leigh D, Bagg CE (1954) A rare presenile dementia associated with cortical blindness (Heidenhain’s syndrome). J Neurol Neurosurg Psychiatry 17:129–133
75. Mitteregger G, Vosko M, Krebs B, Xiang W, Kohlmannsperger V, Nolting S, Hamann GF, Kretzschmar HA (2007) The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 17:174–183
76. Miyazono M, Kitamoto T, Doh-ura K, Iwaki T, Tateishi J (1992) Creutzfeldt–Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 84:349–354
77. Mizutani T, Okumura A, Oda M, Shiraki H (1981) Panencephalopathic type of Creutzfeldt–Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry 44:103–115
78. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, Gray F, Cortelli P, Montagna P, Ghetti B et al (1994) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839–2842
79. Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167–176
80. Moser M, Colello RJ, Pott U, Oesch B (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14:509–517
81. Nevin S, Mc MW, Behrman S, Jones DP (1960) Subacute spongiform encephalopathy—a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 83:519–564
82. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, Dell’Omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U (2006) Efficient transmission and characterization of Creutzfeldt–Jakob disease strains in bank voles. PLoS Pathog 2:e12
83. Notari S, Capellari S, Giese A, Westner I, Baruzzi A, Ghetti B, Gambetti P, Kretzschmar HA, Parchi P (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279:16797–16804
84. Notari S, Capellari S, Langeveld J, Giese A, Strammiello R, Gambetti P, Kretzschmar HA, Parchi P (2007) Arefinedmethod for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt–Jakob disease is not the rule. Lab Invest 87:1103–1112
85. Notari S, Strammiello R, Capellari S, Giese A, Cescatti M, Grassi J, Ghetti B, Langeveld JP, Zou WQ, Gambetti P, Kretzschmar HA, Parchi P (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt–Jakob disease. J Biol Chem 283:30557–30565
86. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352:340–342
87. Palmer MS, Mahal SP, Campbell TA, Hill AF, Sidle KC, Laplanche JL, Collinge J (1993) Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet 2:541–544
88. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE et al (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90:10962–10966
89. Pan T, Colucci M, Wong BS, Li R, Liu T, Petersen RB, Chen S, Gambetti P, Sy MS (2001) Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J Biol Chem 276:37284–37288
90. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H (1997) Typing prion isoforms. Nature 386:232–234
91. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778
92. Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, Zou WQ, Kretzschmar H, Ghetti B, Brown P (2010) Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 133:3030–3042
93. Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw JJ, Gajdusek DC, Gambetti P (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann- Straussler-Scheinker disease. Proc Natl Acad Sci USA 95:8322–8327
94. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
95. Parchi P, Notari S, Weber P, Schimmel H, Budka H, Ferrer I, Haik S, Hauw JJ, Head MW, Ironside JW, Limido L, Rodriguez A, Strobel T, Tagliavini F, Kretzschmar HA (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt–Jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol 19:384–391
96. Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, Zerr I, Roncaroli F, Cras P, Ghetti B, Pocchiari M, Kretzschmar H, Capellari S (2009) Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659–671
97. Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SG (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10172
98. Park TS, Kleinman GM, Richardson EP (1980) Creutzfeldt–Jakob disease with extensive degeneration of white matter. Acta Neuropathol 52:239–242
99. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10:854–863
100. Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271:12661–12668
101. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, Dickson DW, Vinters HV, Zimmerman TR, Mackenzie IR, Kish SJ, Ang LC, De Carli C, Pocchiari M, Brown P, Gibbs CJ Jr, Gajdusek DC, Bugiani O, Ironside J, Tagliavini F, Ghetti B (1998) Phenotypic variability of Gerstmann-Straussler- Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57:979–988
102. Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR, Supattapone S (2009) Prion protein glycosylation is not required for strain-specific neurotropism. J Virol 83:5321–5328
103. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt–Jakob disease. Lancet Neurol 4:805–814
104. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383
105. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt–Jakob disease: cooccurrence of different types of PrP(Sc) in the same brain. Neurology 53:2173–2176
106. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382:180–182
107. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4:1157–1165
108. Salvatore M, Genuardi M, Petraroli R, Masullo C, D’Alessandro M, Pocchiari M (1994) Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt–Jakob disease. Hum Genet 94:375–379
109. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I (2006) CSF tests in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology 67:637–643
110. Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A, Glatzel M (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt–Jakob disease. PLoS Med 3:e14
111. Schoene WC, Masters CL, Gibbs CJ Jr, Gajdusek DC, Tyler HR, Moore FD, Dammin GJ (1981) Transmissible spongiform encephalopathy (Creutzfeldt–Jakob disease). Atypical clinical and pathological findings. Arch Neurol 38:473–477
112. Schulman S (1957) Bilateral symmetrical degeneration of the thalamus: a clinicopathological study. J Neuropathol Exp Neurol 16:446–470
113. Schulz-Schaeffer WJ, Giese A, Windl O, Kretzschmar HA (1996) Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt–Jakob disease. Clin Neuropathol 15:353–357
114. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51–56
115. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T (1998) Protective prion protein polymorphisms against sporadic Creutzfeldt–Jakob disease. Lancet 351:419
116. Somerville RA, Hamilton S, Fernie K (2005) Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. J Gen Virol 86:241–246
117. Stack MJ, Chaplin MJ, Clark J (2002) Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol 104:279–286
118. Stahl N, Baldwin MA, Hecker R, Pan KM, Burlingame AL, Prusiner SB (1992) Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31:5043–5053
119. Stern K (1939) Severe dementia associated with bilateral symmetrical degeneration of the thalamus. Brain 62:157–171
120. Stimson E, Hope J, Chong A, Burlingame AL (1999) Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38:4885–4895
121. Tagliavini F, Prelli F, Ghiso J, Bugiani O, Serban D, Prusiner SB, Farlow MR, Ghetti B, Frangione B (1991) Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kDa fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 10:513–519
122. Thackray AM, Hopkins L, Klein MA, Bujdoso R (2007) Mouseadapted ovine scrapie prion strains are characterized by different conformers of PrPSc. J Virol 81:12119–12127
123. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, Laude H, Beringue V (2010) The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 6:e1000859
124. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, Ironside JW, Haik S, Basset-Leobon C, Lacroux C, Peoch K, Streichenberger N, Langeveld J, Head MW, Grassi J, Hauw JJ, Schelcher F, Delisle MB, Andreoletti O (2008) Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt–Jakob disease. PLoS Pathog 4:e1000029
125. Van Rossum A (1968) Spastic pseudosclerosis (Creutzfeldt–Jakob disease). In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. North Holland, Amsterdam, pp 726–760
126. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1:55–59
127. Will RG, Matthews WB (1984) A retrospective study of Creutzfeldt–Jakob disease in England and Wales 1970–79. I. Clinical features. J Neurol Neurosurg Psychiatry 47:134–140
128. Williams A, Lucassen PJ, Ritchie D, Bruce M (1997) PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144:433–438
129. Williams AE, Lawson LJ, Perry VH, Fraser H (1994) Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 20:47–55
130. Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KC, Palmer MS, Collinge J (1996) Genetic basis of Creutzfeldt–Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264
131. Wu Y, Brown WT, Robakis NK, Dobkin C, Devine-Gage E, Merz P, Wisniewski HM (1987) A PvuII RFLP detected in the human prion protein (PrP) gene. Nucleic Acids Res 15:3191
132. Yull HM, Ironside JW, Head MW (2009) Further characterisation of the prion protein molecular types detectable in the NIBSC Creutzfeldt–Jakob disease brain reference materials. Biologicals 37:210–215
133. Zanusso G, Farinazzo A, Fiorini M, Gelati M, Castagna A, Righetti PG, Rizzuto N, Monaco S (2001) pH-dependent prion protein conformation in classical Creutzfeldt–Jakob disease. J Biol Chem 276:40377–40380
134. Zanusso G, Ferrari S, Conte S, Mellina V, Sacchi V, Rizzuto N, Monaco S (2006) A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. Brain Pathol 16:237–238
135. Zeidler M, Sellar RJ, Collie DA, Knight R, Stewart G, Macleod MA, Ironside JW, Cousens S, Colchester AC, Hadley DM, Will RG (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt–Jakob disease. Lancet 355:1412–1418
136. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt–Jakob disease. J Biol Chem 278:40429–40436
137. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, Dickson D, Honig L, Torres JM, Mastrianni J, Capellari S, Giaccone G, Belay ED, Schonberger LB, Cohen M, Perry G, Kong Q, Parchi P, Tagliavini F, Gambetti P (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68:162–172